Jessica Hutchins
Pediatric Endocrinology · Macon, GANPI 1366763112
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Sanofi-aventis U.S. LLC accounts for 62.3% of it on its own, with 36 other manufacturers making up the rest. 2025 is the largest year on record at $9,908, more than ten times the $293 reported in 2019.
Across 300 payments — averaging $68.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$13K
- Tandem Diabetes Care, Inc.$2K
- Abbott$637
- Xeris Pharmaceuticals, Inc.$484
- AbbVie$465
- Ascendis Pharma Endocrinology Inc$404
- plus $4K from 31 others
What the payments were for
- Speaking & faculty fees$11,99458%
- Travel & lodging$1,2896%
- Food & beverage$7,10335%
- Education$1241%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 20 | $12,769 |
| Tandem Diabetes Care, Inc. | 22 | $2,210 |
| Abbott | 31 | $637 |
| Xeris Pharmaceuticals, Inc. | 27 | $484 |
| AbbVie | 28 | $465 |
| Ascendis Pharma Endocrinology Inc | 19 | $404 |
| Novo Nordisk | 13 | $361 |
| BETA Bionics, Inc. | 6 | $338 |
| Azurity Pharmaceuticals, Inc. | 16 | $316 |
| AstraZeneca | 8 | $294 |
| Dexcom, Inc. | 13 | $240 |
| Kyowa Kirin, Inc. | 7 | $212 |
| IBSA Pharma Inc. | 11 | $206 |
| Insulet Corporation | 8 | $174 |
| Tolmar, Inc. | 8 | $156 |
| Pfizer | 8 | $146 |
| Rhythm Pharmaceuticals, Inc. | 7 | $146 |
| Medtronic(2 entities) | 7 | $123 |
| Endo Pharmaceuticals Inc. | 6 | $115 |
| Lilly USA, LLC | 6 | $102 |
| Sandoz | 4 | $76 |
| Tolmar Pharmaceuticals, Inc. | 4 | $74 |
| Neurocrine Biosciences, Inc. | 3 | $73 |
| Sequel Med Tech, LLC | 1 | $54 |
| Amneal Pharmaceuticals LLC | 3 | $54 |
| Companion Medical, Inc. | 2 | $50 |
| Zealand Pharma US, Inc. | 2 | $29 |
| Baxter Healthcare | 1 | $25 |
| Eton Pharmaceuticals, Inc. | 1 | $23 |
| Amphastar Pharmaceuticals, Inc. | 1 | $23 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| Biomarin Pharmaceutical Inc. | 1 | $21 |
| Neurelis, Inc. | 1 | $20 |
| Arbor Pharmaceuticals, Inc. | 1 | $20 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| BD | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TZIELD$12,374
- t:slim X2 Insulin Pump with Control-IQ$1,710
- iLet Bionic Pancreas$389
- CRYSVITA$125
- Sogroya$110
- t:slim X2 insulin pump$101
How this compares
$20,510 in reported general payments places this provider in the 85th percentile of 30 pediatric endocrinology providers in Georgia.
Other pediatric endocrinology in Macon
- Tarek BisatMacon$3K
- Eric VelazquezMacon$3K
- Quentin VanmeterAtlanta$215K
- Toni KimSandy Springs$160K
- Eric FelnerAtlanta$24K
- Anil PiyaSavannah$14K
- Juliana Vera OrtizNewnan$13K
- Daniel HsiaAtlanta$6K
- Jacqueline ChanAugusta$3K
- Joey LowCumming$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.